remestemcel-L

Mesoblast Sees Path Forward for Twice-Rejected Cell Therapy After FDA Meeting
BioSpace
Thu, 09/21/23 - 10:38 am
Mesoblast
remestemcel-L
FDA
graft vs host disease
FDA Blocks Mesoblast Cell Therapy Again, Asks for More Data
BioSpace
Sun, 08/6/23 - 09:34 pm
Mesoblast
remestemcel-L
FDA
graft vs host disease
cell therapy
FDA rejects Mesoblast's cell therapy for bone marrow transplant complications
Yahoo/Reuters
Fri, 08/4/23 - 12:07 pm
Mesoblast
FDA
cell therapy
bone marrow transplants
remestemcel-L
FDA Action Alert: Mesoblast, Sage/Biogen and Galera
BioSpace
Mon, 07/31/23 - 10:05 am
FDA
graft vs host disease
head and neck cancer
postpartum depression
major depressive disorder
Mesoblast
remestemcel-L
Biogen
SAGE Therapeutics
zuranolone
Galera Therapeutics
avasopasem manganese
2 years after rejection, Mesoblast touts long-term cell therapy survival data as key to FDA resubmission
Fierce Biotech
Sun, 11/27/22 - 07:05 pm
Mesoblast
FDA
cell therapy
remestemcel-L
graft vs host disease
Mesoblast pummelled as Novartis exits COVID deal
Pharmaforum
Tue, 12/14/21 - 10:42 am
Novartis
Mesoblast
stem cells
remestemcel-L
COVID-19
Mesoblast shares plunge 32% after stem-cell therapy not likely to meet target for reducing mortality due to COVID-19
Seeking Alpha
Fri, 12/18/20 - 10:57 am
Mesoblast
clinical trials
remestemcel-L
COVID-19
Novartis Inks $1.35 Billion Deal with Mesoblast for Remestemcel-L for COVID-19 ARDS
BioSpace
Fri, 11/20/20 - 11:08 am
Novartis
Mesoblast
remestemcel-L
COVID-19
ARDS
clinical trials
Mesoblast hit by FDA rejection, request to run another trial
Fierce Biotech
Fri, 10/2/20 - 12:38 pm
Mesoblast
cell therapy
clinical trials
remestemcel-L
graft vs host disease
FDA
Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon
Forbes
Sat, 05/2/20 - 11:16 pm
Mesoblast
Australia
clinical gtrials
ARDS
COVID-19
stem cells
remestemcel-L
Mesoblast poised to file cell therapy for GVHD in US
Pharmaforum
Wed, 04/17/19 - 09:44 am
Mesoblast
stem cells
graft vs host disease
FDA
remestemcel-L